Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Polycythemia"" wg kryterium: Temat


Tytuł:
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
Autorzy:
Theocharides A; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Gisslinger H; Department of Internal Medicine I, Hematology, Medical University of Vienna, Vienna, Austria.
De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli IRCCS, Roma, Italy.
Accurso V; U.O.C. Ematologia AZ.Osp.Univ. Policlinico Paolo Giaccone Palermo, Palermo, Italy.
Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Devos T; Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium.
Egyed M; Hematológiai Osztály, Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvar, Hungary.
Lippert E; Service Hématologie, CHU de Brest, Brest, France.
Delgado RG; Servicio de Hematologia, Hospital Virgen de la Victoria, Malaga, Spain.
Cantoni N; Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Dahm AEA; Avdeling for Blodsykdommer, Akershus Universitetssykehus, Lørenskog, Norway.
Sotiropoulos D; Heamatology Clinic, General Hospital of Thessaloniki G Papanikolaou, Thessaloniki, Greece.
Houtsma E; Novartis Global Service Center, Dublin, Ireland.
Smyth A; Novartis Pharmaceuticals AG, Basel, Switzerland.; Novartis Pharmaceuticals UK Limited, London, UK.
Iqbal A; Novartis Global Service Center, Dublin, Ireland.
Di Matteo P; Novartis Farma SpA, Origgio, Italy.
Zuurman M; Novartis Pharmaceuticals AG, Basel, Switzerland.
Te Boekhorst PAW; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 379-391. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Hydroxyurea*/adverse effects
Polycythemia Vera*/diagnosis
Polycythemia Vera*/drug therapy
Pyrazoles*
Humans ; Middle Aged ; Nitriles ; Pyrimidines/therapeutic use
Czasopismo naukowe
Tytuł:
Polycythemia Secondary to Renal Hemangioblastoma: A Case Report and Literature Review.
Autorzy:
Lee Y; Department of Anatomy and Pathology, Taipei City Hospital Heping Branch, Taipei, Taiwan.
Cheng SM; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
Hwang DY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
Chiu YL; Graduate Institute of Medicine, Yuan-Ze University, Taoyuan, Taiwan.; Department of Medical Research, Far Eastern Memorial Hospital, New Taipei, Taiwan.
Chou YH; Department of Anatomical Pathology, Far Eastern Memorial Hospital, New Taipei, Taiwan.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 140-144. Date of Electronic Publication: 2023 May 07.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/complications
Carcinoma, Renal Cell*/diagnosis
Carcinoma, Renal Cell*/pathology
Erythropoietin*/genetics
Hemangioblastoma*/complications
Hemangioblastoma*/diagnosis
Kidney Neoplasms*/complications
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/pathology
Polycythemia*/etiology
Polycythemia*/complications
Humans ; Male ; Young Adult ; Kidney/pathology
Czasopismo naukowe
Tytuł:
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Autorzy:
Barbui T; FROM, Fondazione Per La Ricerca Ospedale Di Bergamo ETS, Papa Giovanni XXIII Hospital, 24127, Bergamo, Italy. .
Carobbio A; FROM, Fondazione Per La Ricerca Ospedale Di Bergamo ETS, Papa Giovanni XXIII Hospital, 24127, Bergamo, Italy.
De Stefano V; Dipartimento Di Scienze Radiologiche Ed Ematologiche, Sezione Di Ematologia, Università Cattolica del Sacro Cuore-Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Alvarez-Larran A; Hematology Department, Hospital Clínic, Barcelona, Spain.
Ghirardi A; FROM, Fondazione Per La Ricerca Ospedale Di Bergamo ETS, Papa Giovanni XXIII Hospital, 24127, Bergamo, Italy.
Carioli G; FROM, Fondazione Per La Ricerca Ospedale Di Bergamo ETS, Papa Giovanni XXIII Hospital, 24127, Bergamo, Italy.
Fenili F; FROM, Fondazione Per La Ricerca Ospedale Di Bergamo ETS, Papa Giovanni XXIII Hospital, 24127, Bergamo, Italy.
Rossi E; Dipartimento Di Scienze Radiologiche Ed Ematologiche, Sezione Di Ematologia, Università Cattolica del Sacro Cuore-Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Ciceri F; Unità Operativa Di Ematologia E Trapianto Midollo Osseo, IRCCS Ospedale San Raffaele, Milan, Italy.
Bonifacio M; Dipartimento Di Ingegneria Per La Medicina Di Innovazione, Sezione Di Biomedicina Di Innovazione, Università Di Verona, Verona, Italy.; Dipartimento Di Medicina, Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy.
Iurlo A; UOC Ematologia, Fondazione IRCCS Cá Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Palandri F; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seragnoli', Bologna, Italy.
Benevolo G; SC Ematologia U, A.O.U. Città Della Salute E Della Scienza, Turin, Italy.
Pane F; UOC Di Ematologia E Trapianti Di Midollo, Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples, Italy.; Dipartimento Di Medicina Clinica E Chirurgia, Università Di Napoli Federico II, Naples, Italy.
Ricco A; U.O. Ematologia Con Trapianto Azienda Ospedaliera Universitaria 'Consorziale Policlinico' Di Bari, Bari, Italy.
Carli G; UOC Ematologia, Azienda ULSS 8 Berica Ospedale San Bortolo Di Vicenza, Vicenza, Italy.
Caramella M; Divisione Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Rapezzi D; Divisione Di Ematologia, Azienda Ospedaliera S. Croce E Carle Di Cuneo, Cuneo, Italy.
Musolino C; UOC Ematologia, Azienda Ospedaliera Universitaria Policlinico 'G Martino', Messina, Italy.
Siragusa S; Divisione Ematologia, Azienda Ospedaliera Universitaria Policlinico 'P. Giaccone', Palermo, Italy.
Rumi E; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Divisione Di Ematologia, Fondazione IRCCS Policlinico San Matteo Pavia, Pavia, Italy.
Patriarca A; SCDU Ematologia, Azienda Ospedaliero Universitaria Maggiore Della Carità, Novara, Italy.
Cascavilla N; UO Ematologia IRCCS 'Casa Sollievo Della Sofferenza', San Giovanni Rotondo, Italy.
Mora B; Hematology, Ospedale Di Circolo, ASST Sette Laghi, Varese, Italy.
Cacciola E; UO Di Emostasi/Ematologia Centro Federato FCSA, Dipartimento Di Scienze Mediche, Chirurgiche E Tecnologie Avanzate 'G. F. Ingrassia, Azienda Ospedaliera Universitaria Policlinico 'G. Rodolico-San Marco', Catania, Italy.
Calabresi L; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento Di Medicina Sperimentale E Clinica, Università Di Firenze, Florence, Italy.
Loscocco GG; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento Di Medicina Sperimentale E Clinica, Università Di Firenze, Florence, Italy.
Guglielmelli P; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento Di Medicina Sperimentale E Clinica, Università Di Firenze, Florence, Italy.
Gesullo F; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento Di Medicina Sperimentale E Clinica, Università Di Firenze, Florence, Italy.
Betti S; Dipartimento Di Scienze Radiologiche Ed Ematologiche, Sezione Di Ematologia, Università Cattolica del Sacro Cuore-Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Ramundo F; Dipartimento Di Scienze Radiologiche Ed Ematologiche, Sezione Di Ematologia, Università Cattolica del Sacro Cuore-Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Lunghi F; Unità Operativa Di Ematologia E Trapianto Midollo Osseo, IRCCS Ospedale San Raffaele, Milan, Italy.
Scaffidi L; Dipartimento Di Medicina, Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy.
Bucelli C; UOC Ematologia, Fondazione IRCCS Cá Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Cattaneo D; UOC Ematologia, Fondazione IRCCS Cá Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Vianelli N; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seragnoli', Bologna, Italy.
Bellini M; UOC Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy.
Finazzi MC; UOC Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy.; Dipartimento Di Oncologia Ed Emato-Oncologia, Università Degli Studi Di Milano, Milan, Italy.
Tognoni G; Centro Di Coordinamento Nazionale Dei Comitati Etici, Agenzia Italiana del Farmaco, Rome, Italy.
Rambaldi A; UOC Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy.; Dipartimento Di Oncologia Ed Emato-Oncologia, Università Degli Studi Di Milano, Milan, Italy.
Vannucchi AM; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento Di Medicina Sperimentale E Clinica, Università Di Firenze, Florence, Italy.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Feb; Vol. 103 (2), pp. 437-442. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Clinical Trial, Phase II; Randomized Controlled Trial; Journal Article
MeSH Terms:
Polycythemia Vera*/drug therapy
Polycythemia Vera*/diagnosis
Humans ; Hematocrit ; Risk Factors ; Phlebotomy ; Bloodletting
Czasopismo naukowe
Tytuł:
Activated PRKCD-mediated neutrophil extracellular traps pathway may be the prothrombotic mechanism of neutrophils in polycythemia vera patients based on clinical retrospective analysis and bioinformatics study.
Autorzy:
Zhang Y; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing, China.
Chen K; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Wang M; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Wang Z; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Wang D; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Niu J; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing, China.
Yang E; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing, China.
Li Y; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Graduate School, China Academy of Chinese Medical Sciences, Beijing, China.
Sun Y; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Zhao P; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Liu W; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Lv Y; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: .
Hu X; Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: huxiaomei_.
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Jan 25; Vol. 127, pp. 111366. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/genetics
Polycythemia Vera*/complications
Polycythemia Vera*/metabolism
Extracellular Traps*
Thrombosis*/complications
Thrombosis*/pathology
Thrombophilia*
Humans ; Neutrophils/metabolism ; Retrospective Studies ; Protein Kinase C-delta
Czasopismo naukowe
Tytuł:
Idiopathic erythrocytosis: a germline disease?
Autorzy:
Elli EM; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.
Mauri M; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
D'Aliberti D; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Crespiatico I; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Fontana D; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Redaelli S; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Pelucchi S; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Spinelli S; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Manghisi B; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Cavalca F; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Aroldi A; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Ripamonti A; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Ferrari S; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Palamini S; Tettamanti Research Center, IRCCS, San Gerardo dei Tintori, Monza, Italy.
Mottadelli F; Monza and Brianza Foundation for the Child and his Mother (MBBM), IRCCS, San Gerardo dei Tintori, Monza, Italy.
Massimino L; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Ramazzotti D; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Cazzaniga G; Tettamanti Research Center, IRCCS, San Gerardo dei Tintori, Monza, Italy.
Piperno A; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Gambacorti-Passerini C; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
Piazza R; Division of Hematology and Bone Marrow Transplant Unit, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy. .; Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy. .
Pokaż więcej
Źródło:
Clinical and experimental medicine [Clin Exp Med] 2024 Jan 20; Vol. 24 (1), pp. 11. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia*/diagnosis
Polycythemia*/genetics
Polycythemia Vera*/genetics
Humans ; Mutation ; Iron ; Germ Cells
Czasopismo naukowe
Tytuł:
Masked anemia and hematocrit elevation under sodium glucose transporter inhibitors: findings from a large real-world study.
Autorzy:
Schwarz Y; Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Derech Sheba 2, 5266202, Ramat Gan, Israel. .; Sackler Faculty of Medicine, Tel Aviv University, 6997801, Tel Aviv, Israel. .
Klein P; Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Derech Sheba 2, 5266202, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, 6997801, Tel Aviv, Israel.; Maccabi Health Care Services, Tel-Avia-Jaffa, 6812509, Israel.
Lev-Shalem L; Maccabi Health Care Services, Tel-Avia-Jaffa, 6812509, Israel.
Pokaż więcej
Źródło:
Acta diabetologica [Acta Diabetol] 2024 Jan; Vol. 61 (1), pp. 99-105. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Polycythemia*/chemically induced
Polycythemia*/complications
Polycythemia*/drug therapy
Anemia*/epidemiology
Anemia*/etiology
Adult ; Humans ; Male ; Female ; Retrospective Studies ; Hematocrit ; Sodium-Glucose Transport Proteins/therapeutic use ; Hemoglobins/therapeutic use ; Glucose
Czasopismo naukowe
Tytuł:
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis.
Autorzy:
Shide K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara Kiyotake, Miyazaki, 889-1692, Japan.
Takenaka K; Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
Kitanaka A; Department of Laboratory Medicine, Kawasaki Medical School, Kurashiki, Japan.
Numata A; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Kameda T; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara Kiyotake, Miyazaki, 889-1692, Japan.
Yamauchi T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Inagaki A; Department of Hematology and Oncology, Nagoya City West Medical Center, Nagoya, Japan.
Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
Takami A; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
Ito S; Department of Hematology, Hakodate City Hospital, Hakodate, Japan.
Hagihara M; Department of Hematology, Eiju General Hospital, Tokyo, Japan.
Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
Maekawa T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Okayama, Japan.
Tsutsui M; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Ando M; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Komatsu N; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Ozawa K; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Kurokawa M; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Arai S; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, Mibu, Tochigi, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Shimoda K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara Kiyotake, Miyazaki, 889-1692, Japan. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Jan; Vol. 103 (1), pp. 97-103. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Polycythemia Vera*/therapy
Thrombocythemia, Essential*/complications
Thrombocythemia, Essential*/diagnosis
Thrombocythemia, Essential*/drug therapy
Primary Myelofibrosis*/diagnosis
Primary Myelofibrosis*/etiology
Primary Myelofibrosis*/drug therapy
Humans ; Aged ; Prospective Studies
Czasopismo naukowe
Tytuł:
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology.
Autorzy:
Garrote M; Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain. .; Hematopathology Unit, Pathology Department, Hospital Clínic, Barcelona, Spain. .; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. .
López-Guerra M; Hematopathology Unit, Pathology Department, Hospital Clínic, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro Investigación Biomédica en Red (CIBER) Oncología (CIBERONC) y Enfermedades Hepáticas y Digestivas (CIBEREHED), Madrid, Spain.
García-Pagán JC; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro Investigación Biomédica en Red (CIBER) Oncología (CIBERONC) y Enfermedades Hepáticas y Digestivas (CIBEREHED), Madrid, Spain.; Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clínic, Barcelona, Spain.
Arellano-Rodrigo E; Hemotherapy and Hemostasis Department, Hospital Clínic, Barcelona, Spain.
Ferrer-Marín F; Hematology Department, Hospital Morales-Messeguer, Murcia, Spain.
Hernández-Boluda JC; Hematology Department, Hospital Clínico-INCLIVA, Valencia, Spain.
Bellosillo B; Centro Investigación Biomédica en Red (CIBER) Oncología (CIBERONC) y Enfermedades Hepáticas y Digestivas (CIBEREHED), Madrid, Spain.; Pathology Department, Hospital del Mar, Barcelona, Spain.
Nomdedeu M; Hemotherapy and Hemostasis Department, Hospital Clínic, Barcelona, Spain.
Hernández-Gea V; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro Investigación Biomédica en Red (CIBER) Oncología (CIBERONC) y Enfermedades Hepáticas y Digestivas (CIBEREHED), Madrid, Spain.; Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clínic, Barcelona, Spain.
Triguero A; Hematology Department, Hospital Clínic, Barcelona, Spain.
Guijarro F; Hematopathology Unit, Pathology Department, Hospital Clínic, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Álamo J; Hematopathology Unit, Pathology Department, Hospital Clínic, Barcelona, Spain.
Baiges A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro Investigación Biomédica en Red (CIBER) Oncología (CIBERONC) y Enfermedades Hepáticas y Digestivas (CIBEREHED), Madrid, Spain.; Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clínic, Barcelona, Spain.
Turon F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro Investigación Biomédica en Red (CIBER) Oncología (CIBERONC) y Enfermedades Hepáticas y Digestivas (CIBEREHED), Madrid, Spain.; Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clínic, Barcelona, Spain.
Colomer D; Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Hematopathology Unit, Pathology Department, Hospital Clínic, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro Investigación Biomédica en Red (CIBER) Oncología (CIBERONC) y Enfermedades Hepáticas y Digestivas (CIBEREHED), Madrid, Spain.
Cervantes F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Alvarez-Larrán A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Hospital Clínic, Barcelona, Spain.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 737-747. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/complications
Polycythemia Vera*/genetics
Polycythemia Vera*/diagnosis
Thrombocythemia, Essential*/complications
Thrombocythemia, Essential*/genetics
Thrombocythemia, Essential*/diagnosis
Venous Thrombosis*/genetics
Thrombosis*/etiology
Thrombosis*/genetics
Humans ; Adult ; Middle Aged ; Genomics ; Disease Progression ; Janus Kinase 2/genetics
Czasopismo naukowe
Tytuł:
SOHO State of the Art Update and Next Questions: Novel Therapies for Polycythemia Vera.
Autorzy:
Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030. Electronic address: .
Chifotides HT; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Mar; Vol. 24 (3), pp. 141-148. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Polycythemia Vera*/drug therapy
Nitriles*
Pyrimidines*
Humans ; Hydroxyurea/therapeutic use ; Quality of Life ; Pyrazoles/therapeutic use
Czasopismo naukowe
Tytuł:
Ischemic stroke as an initial performance of polycythemia vera in young adults: A case report and literature review.
Autorzy:
Hui S; Department of Graduate School, Hebei Medical University, Shijiazhuang, Hebei, China.; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Zhao J; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.; Biology Post-doctoral Research Stations, Hebei Normal University, Shijiazhuang, Hebei, China.
Huo T; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.; Biology Post-doctoral Research Stations, Hebei Normal University, Shijiazhuang, Hebei, China.
Dong L; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.; Biology Post-doctoral Research Stations, Hebei Normal University, Shijiazhuang, Hebei, China.
Xie Y; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.; Biology Post-doctoral Research Stations, Hebei Normal University, Shijiazhuang, Hebei, China.
Wang X; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.; Department of Graduate School, North China University of Science and Technology, Tangshan, Hebei, China.
Zhang M; Department of Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2024 Feb 16; Vol. 103 (7), pp. e36953.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Polycythemia Vera*/genetics
Ischemic Stroke*/diagnosis
Ischemic Stroke*/etiology
Ischemic Stroke*/therapy
Female ; Humans ; Young Adult ; Aged ; Adolescent ; Adult ; Male ; Janus Kinase 2/genetics ; Bone Marrow/pathology ; Mutation
Czasopismo naukowe
Tytuł:
Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow niche.
Autorzy:
Flosdorf N; Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Institute for Cell and Tumor Biology, RWTH Aachen University Medical School, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
Böhnke J; Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
de Toledo MAS; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Lutterbach N; Institute for Cell and Tumor Biology, RWTH Aachen University Medical School, Aachen, Germany.
Lerma VG; Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Graßhoff M; Institute of Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany.
Olschok K; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Gupta S; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Tharmapalan V; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Institute for Stem Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.
Schmitz S; Institute for Cell and Tumor Biology, RWTH Aachen University Medical School, Aachen, Germany.
Götz K; Institute for Cell and Tumor Biology, RWTH Aachen University Medical School, Aachen, Germany.
Schüler HM; Institute for Human Genetics and Genome Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany; Center for Rare Diseases, Medical Faculty, and University Hospital Düsseldorf Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Maurer A; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Sontag S; Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Küstermann C; Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Seré K; Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Institute for Cell and Tumor Biology, RWTH Aachen University Medical School, Aachen, Germany.
Wagner W; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Institute for Stem Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.
Costa IG; Institute of Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany.
Brümmendorf TH; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Koschmieder S; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Chatain N; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Castilho M; Eindhoven University of Technology, Eindhoven, the Netherlands.
Schneider RK; Institute for Cell and Tumor Biology, RWTH Aachen University Medical School, Aachen, Germany.
Zenke M; Department of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Hospital, Aachen, Germany. Electronic address: .
Pokaż więcej
Źródło:
Stem cell reports [Stem Cell Reports] 2024 Feb 13; Vol. 19 (2), pp. 224-238. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Induced Pluripotent Stem Cells*
Polycythemia Vera*/genetics
Polycythemia Vera*/pathology
Humans ; Mice ; Animals ; Bone Marrow/pathology ; Megakaryocytes ; Janus Kinase 2/genetics ; Phenotype ; Fibrosis ; Mutation
Czasopismo naukowe
Tytuł:
The effect of polycythemia vera on choroidal thickness and retrobulbar blood flow.
Autorzy:
Aydın N; Department of Ophthalmology, Amasya University, Sabuncuoglu Serefeddin Training and Research Hospital, Amasya, Turkey.
Tufek M; Department of Ophthalmology, Amasya University, Sabuncuoglu Serefeddin Training and Research Hospital, Amasya, Turkey. Electronic address: .
Pokaż więcej
Źródło:
Photodiagnosis and photodynamic therapy [Photodiagnosis Photodyn Ther] 2024 Feb; Vol. 45, pp. 103985. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Polycythemia Vera*
Photochemotherapy*/methods
Humans ; Prospective Studies ; Blood Flow Velocity/physiology ; Photosensitizing Agents ; Hemodynamics ; Choroid/diagnostic imaging
Czasopismo naukowe
Tytuł:
Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia.
Autorzy:
Grenier JMP; Etablissement Français du Sang PACA-Corse, Aix Marseille University, CNRS, ADES UMR 7268, 13005 Marseille, France.; Laboratoire d'Excellence GR-Ex, 75015 Paris, France.
El Nemer W; Etablissement Français du Sang PACA-Corse, Aix Marseille University, CNRS, ADES UMR 7268, 13005 Marseille, France.; Laboratoire d'Excellence GR-Ex, 75015 Paris, France.
De Grandis M; Etablissement Français du Sang PACA-Corse, Aix Marseille University, CNRS, ADES UMR 7268, 13005 Marseille, France.; Laboratoire d'Excellence GR-Ex, 75015 Paris, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 24; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Polycythemia Vera*
Thrombocythemia, Essential*/complications
Thrombosis*/complications
Thrombocytosis*/pathology
Humans ; Erythrocytes/pathology
Czasopismo naukowe
Tytuł:
Differences in Clinical Outcomes Between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients.
Autorzy:
Lee SE; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Hong J; Divison of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Bang SM; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Park J; Divison of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Choi CW; Divison of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
Bae SH; Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Kim MK; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
Yoon SY; Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.
Kim SY; Divison of Hematology, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University, Seoul, Korea. .
Pokaż więcej
Źródło:
Journal of Korean medical science [J Korean Med Sci] 2024 Jan 22; Vol. 39 (3), pp. e24. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Hydroxyurea*/pharmacology
Polycythemia Vera*/drug therapy
Humans ; Disease Progression ; Heart Disease Risk Factors ; Thrombosis/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Neuroimaging Findings of Polycythemia with Secondary Acute Ischemia.
Autorzy:
Alrehaili MN; Department of Radiology, King Salman Bin Abdulaziz Medical City, Madinah, Saudi Arabi.
Alharbi ST
Pokaż więcej
Źródło:
Neurology India [Neurol India] 2024 Jan 01; Vol. 72 (1), pp. 193-194. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia*/complications
Polycythemia*/diagnostic imaging
Humans
Czasopismo naukowe
Tytuł:
Association between hemoglobin concentration and hypertension risk in native Tibetans at high altitude.
Autorzy:
Liu X; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Yang C; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Zhang X; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Ye R; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Li X; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Zhang Z; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Jia S; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Sun L; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Meng Q; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Chen X; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2024 Jan; Vol. 26 (1), pp. 17-23. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia*
Hypertension*/epidemiology
East Asian People*
Humans ; Altitude ; Cross-Sectional Studies ; Hemoglobins
Czasopismo naukowe
Tytuł:
Prevalence and diagnostic performance of iron deficiency in polycythemia.
Autorzy:
Randrianarisoa RMF; Department of Internal Medicine, Joseph Raseta Befelatanana Hospital, Antananarivo, Madagascar.
Ramanandafy H; Department of Internal Medicine, Joseph Raseta Befelatanana Hospital, Antananarivo, Madagascar.
Mania A; Department of Internal Medicine, Henri Mondor Hospital, Aurillac, France.
Monjanel H; Department of Internal Medicine, Henri Mondor Hospital, Aurillac, France.
Trouillier S; Department of Internal Medicine, Henri Mondor Hospital, Aurillac, France.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2204621.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia*/diagnosis
Polycythemia*/epidemiology
Polycythemia Vera*/complications
Polycythemia Vera*/diagnosis
Polycythemia Vera*/epidemiology
Iron Deficiencies*
Humans ; Middle Aged ; Retrospective Studies ; Prevalence ; Ferritins
Czasopismo naukowe
Tytuł:
Chronic obstructive pulmonary disease burden, grades and erythrocytosis at a tertiary hospital in western Uganda.
Autorzy:
Banturaki A; Department of Internal Medicine, Kampala International University-Teaching Hospital, P.O. BOX 71, Ishaka- Bushenyi, Uganda. .
Munyambalu DK; Department of Internal Medicine, Kampala International University-Teaching Hospital, P.O. BOX 71, Ishaka- Bushenyi, Uganda.
Kajoba D; Department of Paediatrics and Child Health, Kampala International University-Teaching Hospital, Ishaka- Bushenyi, Uganda.
Onchoke VB; Department of Internal Medicine, Kampala International University-Teaching Hospital, P.O. BOX 71, Ishaka- Bushenyi, Uganda.
Peris A; Department of Internal Medicine, Kampala International University-Teaching Hospital, P.O. BOX 71, Ishaka- Bushenyi, Uganda.
Ryamugwiza P; Department of Internal Medicine, Kampala International University-Teaching Hospital, P.O. BOX 71, Ishaka- Bushenyi, Uganda.
Amandua J; Department of Internal Medicine, Kampala International University-Teaching Hospital, P.O. BOX 71, Ishaka- Bushenyi, Uganda.
Akaba K; Department of Internal Medicine, Kampala International University-Teaching Hospital, P.O. BOX 71, Ishaka- Bushenyi, Uganda.
Pokaż więcej
Źródło:
BMC pulmonary medicine [BMC Pulm Med] 2024 Mar 06; Vol. 24 (1), pp. 119. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia*/epidemiology
Pulmonary Disease, Chronic Obstructive*/epidemiology
Adult ; Female ; Humans ; Middle Aged ; Male ; Tertiary Care Centers ; Cross-Sectional Studies ; Uganda/epidemiology
Czasopismo naukowe
Tytuł:
Idiopathic erythrocytosis: A diagnostic and management challenge with emerging areas for exploration.
Autorzy:
O'Neill C; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
O'Connell C; Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 774-783. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Polycythemia*/genetics
Humans ; Cohort Studies ; Genetic Testing ; Prognosis
Czasopismo naukowe
Tytuł:
Engineering a humanized animal model of polycythemia vera with minimal JAK2 V617F mutant allelic burden.
Autorzy:
Parsons TM; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110.
Krishnan A; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110.
Dunuwille WMB; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110.
Young AL; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110.
Arand J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110.
Han W; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110.
Challen GA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA, 63110. .
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 968-973. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/genetics
Animals
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies